World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on June 1, 2026

Jun. 1, 2026

Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus

Indeterminate GlobeNewswire

Jun. 1, 2026

Blue Heron Design-Build Firm Names Kevin Adams as CEO

Indeterminate GlobeNewswire

Jun. 1, 2026

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

Indeterminate GlobeNewswire

Jun. 1, 2026

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

Indeterminate GlobeNewswire

Jun. 1, 2026

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

Jun. 1, 2026

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

Indeterminate GlobeNewswire

Jun. 1, 2026

Fast Track Entertainment Brings Dream Cruises’ 10th Anniversary Celebrity Strategy to Life with Chef Tommie Lee Onboard ‘Genting Dream’

Indeterminate GlobeNewswire

Jun. 1, 2026

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

Indeterminate GlobeNewswire

Jun. 1, 2026

Wave Life Sciences to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jun. 1, 2026

Oak Hill Bio Raises $32.5 Million Series A Financing to Advance Antisense Oligonucleotide Therapy Rugonersen to Phase 3 Study in Angelman Syndrome

Indeterminate GlobeNewswire

Jun. 1, 2026

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

How Advanced Drug Delivery Could Improve Existing Cancer Treatments

Indeterminate GlobeNewswire

Jun. 1, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Indeterminate GlobeNewswire

Jun. 1, 2026

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Indeterminate GlobeNewswire

Jun. 1, 2026

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

LifeMD Appoints Umesh Sripad as Chief Technology Officer

Indeterminate GlobeNewswire